LB Pharmaceuticals Inc. (LBRX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
31. 41
+0.82
+2.6806%
$
900.73M Market Cap
- P/E Ratio
- Div Yield
147,900 Volume
- Eps
$ 30.59
Previous Close 
Want to track LBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LB Pharmaceuticals Inc. (LBRX) Statistics
Valuation metrics
Market Cap 900.73M
Enterprise value 583.53M
Trailing P/E (ttm) -1.46
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) -
Price/Book (mrq) 2.34
Enterprise Value/Revenue -
Enterprise Value/EBITDA -14.94
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 192.91K
Average volume (90 days) 212.84K
Price summary
52-Week low 13.36
52-Week high 35.34
Beta -
50-Day moving average 30.52
200-Day moving average 25.74
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.1%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 35.68%
Book value per share (mrq) 13.41
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
